Come up with a name for your new list and we'll add to it:
Agensys was acquired by
Astellas Pharma on December 10, 2007.
Agensys, Inc. is developing a pipeline of therapeutic fully human monoclonal antibodies (MAbs) to treat solid tumor cancers based on its own proprietary targets. The Company has discovered and validat…